MENU
+Compare
AGNPF
Stock ticker: OTC
AS OF
Jun 26 closing price
Price
$0.06
Change
+$0.01 (+20.00%)
Capitalization
1.39M

AGNPF Algernon Pharmaceuticals Inc. Forecast, Technical & Fundamental Analysis

Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis, and chronic cough... Show more

AGNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AGNPF with price predictions
Jun 27, 2025

Momentum Indicator for AGNPF turns negative, indicating new downward trend

AGNPF saw its Momentum Indicator move below the 0 level on June 18, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 108 similar instances where the indicator turned negative. In of the 108 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for AGNPF turned negative on June 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 56 similar instances when the indicator turned negative. In of the 56 cases the stock turned lower in the days that followed. This puts the odds of success at .

AGNPF moved below its 50-day moving average on June 17, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AGNPF crossed bearishly below the 50-day moving average on June 24, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for AGNPF entered a downward trend on June 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 73 cases where AGNPF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 50-day moving average for AGNPF moved above the 200-day moving average on June 27, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.500) is normal, around the industry mean (16.366). P/E Ratio (2.593) is within average values for comparable stocks, (58.189). AGNPF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.247).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AGNPF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AGNPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
AGNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
601 West Broadway
Phone
+1 604 398-4175
Employees
N/A
Web
https://www.algernonpharmaceuticals.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTIS97.600.08
+0.08%
Otis Worldwide Corp
APLE11.840.01
+0.08%
Apple Hospitality REIT
DTSS1.99N/A
N/A
Datasea
EMX2.50-0.06
-2.34%
EMX Royalty Corp
GSM3.66-0.12
-3.17%
Ferroglobe PLC

AGNPF and Stocks

Correlation & Price change

A.I.dvisor tells us that AGNPF and CGEN have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AGNPF and CGEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGNPF
1D Price
Change %
AGNPF100%
N/A
CGEN - AGNPF
23%
Poorly correlated
-1.78%
CYDY - AGNPF
21%
Poorly correlated
-14.17%
VIVS - AGNPF
21%
Poorly correlated
+2.11%
ABCZF - AGNPF
10%
Poorly correlated
N/A
KYMR - AGNPF
8%
Poorly correlated
-3.48%
More